Hedge Fund - DAFNA Capital Management
Syndax Pharmaceuticals Inc (SNDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $5,837,734 | 1.36% | 277,855 | $17.45 |
| 2 | 2025 - Q3 (2025-09-30) | $7,703,300 | 1.9% | 500,702 | $13.09 |
| 3 | 2025 - Q2 (2025-06-30) | $5,090,833 | 1.41% | 543,602 | $11.01 |
| 4 | 2025 - Q1 (2025-03-31) | $6,689,207 | 1.9% | 544,502 | $14.10 |
| 5 | 2024 - Q4 (2024-12-31) | $7,165,266 | 1.82% | 542,002 | $17.11 |
| 6 | 2024 - Q3 (2024-09-30) | $10,139,014 | 2.39% | 526,702 | $20.66 |
| 7 | 2024 - Q2 (2024-06-30) | $13,489,729 | 3.22% | 657,074 | $20.93 |
| 8 | 2024 - Q1 (2024-03-31) | $15,697,861 | 3.57% | 659,574 | $22.30 |
| 9 | 2023 - Q4 (2023-12-31) | $16,047,024 | 3.84% | 742,574 | $15.37 |
| 10 | 2023 - Q3 (2023-09-30) | $6,655,576 | 2.07% | 458,373 | $18.92 |
| 11 | 2023 - Q2 (2023-06-30) | $9,436,772 | 2.58% | 450,873 | $20.82 |
| 12 | 2023 - Q1 (2023-03-31) | $9,442,182 | 2.83% | 447,073 | $24.88 |
| 13 | 2022 - Q4 (2022-12-31) | $11,378,008 | 3.2% | 447,073 | $23.32 |
| 14 | 2022 - Q3 (2022-09-30) | $8,542,000 | 2.29% | 355,487 | $22.44 |
| 15 | 2022 - Q2 (2022-06-30) | $7,138,000 | 1.94% | 370,987 | $16.66 |
| 16 | 2022 - Q1 (2022-03-31) | $6,465,000 | 1.68% | 371,987 | $16.84 |
| 17 | 2021 - Q4 (2021-12-31) | $6,491,000 | 1.63% | 296,535 | $18.48 |
| 18 | 2021 - Q3 (2021-09-30) | $1,542,000 | 0.4% | 80,702 | $16.66 |
| 19 | 2021 - Q2 (2021-06-30) | $2,536,000 | 0.53% | 147,702 | $18.32 |
| 20 | 2021 - Q1 (2021-03-31) | $1,286,000 | 0.3% | 57,500 | $22.59 |
| 21 | 2020 - Q4 (2020-12-31) | $222,000 | 0.06% | 10,000 | $20.74 |
| 22 | 2020 - Q3 (2020-09-30) | $1,516,000 | 0.49% | 102,713 | $15.24 |
| 23 | 2020 - Q2 (2020-06-30) | $5,335,000 | 1.53% | 360,000 | $15.23 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center